FY2025 Earnings Estimate for ISRG Issued By Leerink Partnrs

Intuitive Surgical, Inc. (NASDAQ:ISRG) – Investment analysts at Leerink Partnrs raised their FY2025 earnings estimates for Intuitive Surgical in a research report issued on Tuesday, October 14th. Leerink Partnrs analyst M. Kratky now expects that the medical equipment provider will earn $6.58 per share for the year, up from their prior forecast of $6.56. The consensus estimate for Intuitive Surgical’s current full-year earnings is $6.43 per share.

A number of other analysts also recently issued reports on ISRG. Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. Mizuho lowered their price objective on shares of Intuitive Surgical from $570.00 to $520.00 and set a “neutral” rating on the stock in a research report on Tuesday. UBS Group set a $529.00 price objective on shares of Intuitive Surgical in a research report on Monday. The Goldman Sachs Group lowered their price objective on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a research report on Wednesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Fourteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $582.14.

Intuitive Surgical Stock Down 0.2%

NASDAQ:ISRG opened at $435.61 on Wednesday. The company’s 50 day moving average price is $456.15 and its 200-day moving average price is $496.60. Intuitive Surgical has a 52 week low of $425.00 and a 52 week high of $616.00. The stock has a market cap of $156.16 billion, a price-to-earnings ratio of 60.75, a PEG ratio of 4.58 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. During the same quarter in the prior year, the company posted $1.78 earnings per share. The business’s revenue for the quarter was up 21.4% on a year-over-year basis.

Institutional Trading of Intuitive Surgical

Institutional investors and hedge funds have recently modified their holdings of the company. Chilton Capital Management LLC increased its holdings in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 43 shares during the last quarter. Tobam increased its holdings in Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares during the last quarter. Elite Financial Inc. bought a new stake in Intuitive Surgical in the 1st quarter valued at $26,000. Kilter Group LLC bought a new stake in Intuitive Surgical in the 2nd quarter valued at $27,000. Finally, LFA Lugano Financial Advisors SA bought a new stake in Intuitive Surgical in the 1st quarter valued at $30,000. 83.64% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Amy L. Ladd sold 335 shares of the firm’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the sale, the director directly owned 739 shares in the company, valued at $325,669.91. This trade represents a 31.19% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock worth $21,716,492 in the last three months. Company insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.